专利号:US-8481519-B2 优先权日:2005-02-05 标题 :Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostatic hyperplasia, prostate carcinoma and spinobulbar muscular atrophy 发明人:HOFFMANN HANS-RAINER; MATUSCH RUDOLF; BANIAHMAD ARIA 权利人:HOFFMANN HANS-RAINER; MATUSCH RUDOLF; BANIAHMAD ARIA; LOHMANN THERAPIE SYST LTS 摘要:A method for isolating atraric acid from biological material, atraric acid derivatives, the chemical synthesis thereof, and the use of atraric acid and the derivatives thereof for treating or producing a medicament for treating benign prostate hyperplasia, prostate carcinoma or spinobulbar muscular atrophy is provided. In addition, a basic substance for the development of other agents used for treating benign prostate hyperplasia, prostate carcinoma, or spinobulbar muscular atrophy is provided.
专利号:US-2009143466-A1 优先权日:2005-02-05 标题 :Isolation of Atraric Acid, Synthesis of Atraric Acid Derivatives, and Use of Atraric Acid and the Derivatives Thereof for the Treatment of Benign Prostatic Hyperplasia, Prostate Carcinoma and Spinobulbar Muscular Atrophy
专利号:CA-2596634-C 优先权日:2005-02-05 标题 :Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostatic hyperplasia, prostate carcinoma and spinobulbar muscular atrophy
专利号:ZA-200706107-B 优先权日:2005-02-05 标题 :Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma, and spinobulbar muscular atrophy
专利号:WO-2006081997-A2 优先权日:2005-02-05 标 题:Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma, and spinobulbar muscular atrophy
专利号:DE-102005005399-A1 优先权日:2005-02-05 标题 :Isolation of atraric acid, synthesis of atraric acid derivatives and their use of atraric acid and its derivatives for the treatment of benign prostatic hyperplasia and prostate cancer
1: Shukla I, Azmi L, Gupta SS, Upreti DK, Rao CV. Melioration of anti-hepatotoxic effect by Lichen rangiferinus against alcohol induced liver damage in rats. J Ayurveda Integr Med. 2018 Jan 29. pii: S0975-9476(17)30047-5. doi: 10.1016/j.jaim.2017.08.007. [Epub ahead of print] doi: 10.5941/MYCO.2017.45.4.338. Epub 2017 Dec 31. 3: Stojanović G, Zlatanović I, Zrnzević I, Stanković M, Stankov Jovanović V, Zlatković B. Hypogymnia tubulosa extracts: chemical profile and biological activities. Nat Prod Res. 2017 Sep 13:1-5. doi: 10.1080/14786419.2017.1375926. [Epub ahead of print] doi: 10.1007/s11010-017-3178-7. Epub 2017 Sep 8.
合成参考文献
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198 参考文献:10.1021/np9803777 摘要:Kumar KC S, Müller K. Lichen Metabolites. 1. Inhibitory Action Against Leukotriene B4Biosynthesis by a Non-Redox Mechanism. J. Nat. Prod. 1999 May 06;62(6):817–20. doi: 10.1021/np9803777. 参考文献:10.1021/np980378z 摘要:Kumar KC, Müller K. Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth. J Nat Prod. 1999 Jun;62(6):821–3. doi: 10.1021/np980378z. 参考文献:10.1371/journal.pone.0019836 摘要:Johnson CJ, Bennett JP, Biro SM, Duque-Velasquez JC, Rodriguez CM, Bessen RA, Rocke TE. Degradation of the Disease-Associated Prion Protein by a Serine Protease from Lichens. PLoS ONE. 2011 May 11;6(5):e19836. doi: 10.1371/journal.pone.0019836. 参考文献:10.1177/1934578x1400900419 摘要:Stojanović GS, Stanković M, Stojanović IŽ, Palić I, Milovanović V, Rančić S. Clastogenic Effect of Atranorin, Evernic acid, and Usnic Acid on Human Lymphocytes. Natural Product Communications. 2014 Apr;9(4). doi: 10.1177/1934578x1400900419.